Viewing Study NCT04500561


Ignite Creation Date: 2025-12-24 @ 12:38 PM
Ignite Modification Date: 2025-12-27 @ 10:43 PM
Study NCT ID: NCT04500561
Status: UNKNOWN
Last Update Posted: 2020-08-05
First Post: 2020-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module